{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:28Z","timestamp":1761513028881},"publisher-location":"Boston, MA","reference-count":32,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461349082"},{"type":"electronic","value":"9781461500650"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003]]},"DOI":"10.1007\/978-1-4615-0065-0_14","type":"book-chapter","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T05:15:04Z","timestamp":1316409304000},"page":"219-226","source":"Crossref","is-referenced-by-count":15,"title":["New Therapeutics for the Treatment of Glycosphingolipid Lysosomal Storage Diseases"],"prefix":"10.1007","author":[{"given":"T. D.","family":"Butters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Dwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0959-440X(02)00376-7","volume":"12","author":"ML Allende","year":"2002","unstructured":"Allende, M.L. and Proia, R.L., 2002, Lubricating cell signaling pathways with gangliosides, Curr Opin Struct Biol. 12:587\u2013592.","journal-title":"Curr Opin Struct Biol."},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","volume":"59","author":"U Andersson","year":"2000","unstructured":"Andersson, U., Butters, T.D., Dwek, R.A., and Platt, F.M., 2000, N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo, Biochem Pharmacol 59:821\u2013829.","journal-title":"Biochem Pharmacol"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1021\/cr990292q","volume":"100","author":"TD Butters","year":"2000","unstructured":"Butters, T.D., Dwek, R.A., and Platt, R.M., 2000a, Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders, Chem Rev. 100:4683\u20134696.","journal-title":"Chem Rev."},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1568026033452483","volume":"3","author":"TD Butters","year":"2003","unstructured":"Butters, T.D., Dwek, R.A., and Platt, F.M., 2003a, therapeutic applications of imino sugars in lysosomal storage disorders, Curr Top Med Chem. 3:561\u2013574.","journal-title":"Curr Top Med Chem."},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1098\/rstb.2003.1278","volume":"358","author":"TD Butters","year":"2003","unstructured":"Butters, T.D., Mellor, H.R., Narita, K., Dwek, R.A., and Platt, F.M., 2003b, Small Molecule Therapeutics for the Treatment of Glycolipid Lysosomal Storage Disorders, Phil Trans R Soc Lond B 358:927\u2013945.","journal-title":"Phil Trans R Soc Lond B"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0957-4166(99)00468-1","volume":"11","author":"TD Butters","year":"2000","unstructured":"Butters, T.D., van den Broek, L.A.G.M., Fleet, G.W.J., Krulle, T.M., Wormald, M.R., Dwek, R.A., and Platt, F.M., 2000b, Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis, Tetrahedron:Asymmetry. 11:113\u2013124.","journal-title":"Tetrahedron:Asymmetry."},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","volume":"355","author":"T Cox","year":"2000","unstructured":"Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebicek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., Gow, I., Elstein, D., and Zimran, A., 2000, Novel oral treatment of Gaucher\u2019s Disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis, Lancet. 355:1481\u20131485.","journal-title":"Lancet."},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrd708","volume":"1","author":"RA Dwek","year":"2002","unstructured":"Dwek, R.A., Butters, T.D., Platt, F.M., and Zitzmann, N., 2002, targeting glycosylation as a therapeutic approach, Nature Rev Drug Discovery. 1:65\u201375.","journal-title":"Nature Rev Drug Discovery"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0304-4165(02)00408-7","volume":"1573","author":"HH Freeze","year":"2002","unstructured":"Freeze, H.H., 2002, Human disorders in N-glycosylation and animal models, BBA Gen Subjects. 1573:388\u2013393.","journal-title":"BBA Gen Subjects"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrm947","volume":"3","author":"SD Gadola","year":"2002","unstructured":"Gadola, S.D., Zaccai, N.R., Harlos, K., Shepherd, D., CastroPalomino, J.C., Ritter, G., Schmidt, R.R., Jones, E.Y., and Cerundolo, V., 2002, Structure of human CD1b with bound ligands at 2.3 angstrom, a maze for alkyl chains, Nat Immunol. 3:721\u2013726.","journal-title":"Nat Immunol."},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1517\/13543776.12.8.1215","volume":"12","author":"M Gagnon","year":"2002","unstructured":"Gagnon, M. and Saragovi, H.U., 2002, Gangliosides: therapeutic agents or therapeutic targets?, Expert Opin Ther Patents. 12:1215\u20131223.","journal-title":"Expert Opin Ther Patents"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","volume":"96","author":"M Jeyakumar","year":"1999","unstructured":"Jeyakumar, M., Butters, T.D., CortinaBorja, M., Hunnam, V., Proia, R.L., Perry, V.H., Dwek, R.A., and Platt, F.M., 1999, Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin, Proc Nat Acad Sci USA. 96:6388\u20136393.","journal-title":"Proc Nat Acad Sci USA."},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2990.2002.00422.x","volume":"28","author":"M Jeyakumar","year":"2002","unstructured":"Jeyakumar, M., Butters, T.D., Dwek, R.A., and Platt, F.M., 2002a, Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis, Neuropathol Appl Neurobiol. 28:343\u2013357.","journal-title":"Neuropathol Appl Neurobiol."},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/blood.V97.1.327","volume":"97","author":"M Jeyakumar","year":"2001","unstructured":"Jeyakumar, M., Norflus, F., Tifft, C.J., CortinaBorja, M., Butters, T.D., Proia, R.L., Perry, V.H., Dwek, R.A., and Platt, F.M., 2001, Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation, Blood. 97:327\u2013329.","journal-title":"Blood."},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1006\/nbdi.2002.0511","volume":"10","author":"M Jeyakumar","year":"2002","unstructured":"Jeyakumar, M., Smith, D., EliottSmith, E., CortinaBorja, M., Reinkensmeier, G., Butters, T.D., Lemm, T., Sandhoff, K., Perry, V.H., Dwek, R.A., and Platt, F.M., 2002b, An inducible mouse model of late onset Tay-Sachs disease, Neurobiol Disease. 10:201\u2013210.","journal-title":"Neurobiol Disease."},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1026528921085","volume":"17","author":"T Kobayashi","year":"2000","unstructured":"Kobayashi, T. and Hirabayashi, V., 2000, Lipid membrane domains in cell surface and vacuolar systems, Glycoconjugate J. 17:163\u2013171.","journal-title":"Glycoconjugate J."},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U","volume":"38","author":"T Kolter","year":"1999","unstructured":"Kolter, T. and Sandhoff, K., 1999, Sphingolipids\u2014their metabolic pathways and the pathobiochemistry of neurodegenerative diseases, Angew Chem Int Ed. 38:1532\u20131568.","journal-title":"Angew Chem Int Ed."},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/glycob\/9.11.1263","volume":"9","author":"KW Marek","year":"1999","unstructured":"Marek, K.W., Vijay, I.K., and Marth, J.D., 1999, A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality, Glycobiology. 9:1263\u20131271.","journal-title":"Glycobiology"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1074\/jbc.274.1.451","volume":"274","author":"DL Marks","year":"1999","unstructured":"Marks, D.L., Wu, K.J., Paul, P., Kamisaka, Y., Watanabe, R., and Pagano, R.E., 1999, Oligomerization and topology of the Golgi membrane protein glucosylceramide synthase, J Biol Chem. 274:451\u2013456.","journal-title":"J Biol Chem."},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/bj20020466","volume":"366","author":"HR Mellor","year":"2002","unstructured":"Mellor, H.R., Nolan, J., Pickering, L., Wormald, M.R., Platt, F.M., Dwek, R.A., Fleet, G.W.J., and Butters, T.D., 2002, Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins, Biochem J. 366:225\u2013233.","journal-title":"Biochem J."},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0006-2952(98)00115-4","volume":"56","author":"FM Platt","year":"1998","unstructured":"Platt, F.M. and Butters, T.D., 1998, New therapeutic prospects for the glycosphingolipid lysosomal storage diseases, Biochem Pharmacol. 56:421\u2013430.","journal-title":"Biochem Pharmacol."},{"key":"14_CR22","doi-asserted-by":"crossref","unstructured":"Platt, F.M. and Butters, T.D., 2000, Substrate deprivation: A new therapeutic approach for the glycosphingolipid lysosomal storage diseases, Expert Reviews in Molecular Medicine () 1\u201317.","DOI":"10.1017\/S1462399400001484"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","volume":"269","author":"FM Platt","year":"1994","unstructured":"Platt, F.M., Neises, G.R., Dwek, R.A., and Butters, T.D., 1994a, N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis, J Biol Chem. 269:8362\u20138365.","journal-title":"J Biol Chem."},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","volume":"269","author":"FM Platt","year":"1994","unstructured":"Platt, F.M., Neises, G.R., Karlsson, G.B., Dwek, R.A., and Butters, T.D.,1994b, N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing, J Biol Chem. 269:27108\u201327114.","journal-title":"J Biol Chem."},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.276.5311.428","volume":"276","author":"FM Platt","year":"1997","unstructured":"Platt, F.M. Neises, G.R., Reinkensmeier, G., Townsend, M.J., Perry, V.H., Proia, R.L., Winchester, B., Dwek, R.A., and Butters, T.D., 1997a, Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin, Science. 276:428\u2013431.","journal-title":"Science"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"19365","DOI":"10.1074\/jbc.272.31.19365","volume":"272","author":"FM Platt","year":"1997","unstructured":"Platt, F.M., Reinkensmeier, G., Dwek, R.A., and Butters, T.D., 1997b, Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin, J Biol Chem. 272:19365\u201319372.","journal-title":"J Biol Chem."},{"key":"14_CR27","first-page":"iv","volume":"19","author":"DA Priestman","year":"2000","unstructured":"Priestman, D.A., Platt, F.M., Dwek, R.A., and Butters, T.D., 2000, Imino sugar therapy for type I Gaucher disease, Glycobiology. 19:iv\u2013vi.","journal-title":"Glycobiology"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"15428","DOI":"10.1073\/pnas.192582899","volume":"99","author":"AR Sawkar","year":"2002","unstructured":"Sawkar, A.R., Cheng, W.C., Beutler, E., Wong, C.H., Balch, W.E., and Kelly, J.W., 2002, Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease, Proc NatAcad Sci USA. 99:15428\u201315433.","journal-title":"Proc NatAcad Sci USA."},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1750-3639.1998.tb00145.x","volume":"8","author":"K Suzuki","year":"1998","unstructured":"Suzuki, K., Proia, R.L., and Suzuki, K., 1998, Mouse models of human lysosomal diseases, Brain Path. 8:195\u2013215.","journal-title":"Brain Path."},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1073\/pnas.96.16.9142","volume":"96","author":"T Yamashita","year":"1999","unstructured":"Yamashita, T., Wada, R., Sasaki, T., Deng, C.X., Bierfreund, U., Sandhoff, K., and Proia, R.L., 1999, A vital role for glycosphingolipid synthesis during development and differentiation, Proc Nat Acad Sci USA. 96:9142\u20139147.","journal-title":"Proc Nat Acad Sci USA."},{"key":"14_CR31","volume-title":"Gauchers Disease","author":"A Zimran","year":"1997","unstructured":"Zimran, A., 1997, Gauchers Disease, London, Bailliere Tindall."},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1098\/rstb.2003.1272","volume":"358","author":"A Zimran","year":"2003","unstructured":"Zimran, A. and Elstein, D., 2003, Gaucher disease and the clinical experience with substrate reduction therapy, Phil Trans R Soc Lond B 358:961\u2013966.","journal-title":"Phil Trans R Soc Lond B"}],"container-title":["Advances in Experimental Medicine and Biology","Glycobiology and Medicine"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-0065-0_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T13:34:52Z","timestamp":1638711292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-0065-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"ISBN":["9781461349082","9781461500650"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-0065-0_14","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[2003]]}}}